| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
4 allele, AD pathology, and the clinical expression of Alzheimer’s disease
From the Rush Alzheimer’s Disease Center and Rush Institute for Healthy Aging (Drs. Bennett, Wilson, Schneider, Evans, Aggarwal, and Bienias); Department of Neurological Sciences (Drs. Bennett, Wilson, Schneider, Evans, Aggarwal, Cochran, and Berry-Kravis); Department of Psychology (Dr. Wilson); Department of Pathology (Drs. Schneider and Cochran); Department of Internal Medicine (Drs. Evans and Bienias), Department of Pediatrics (Dr. Berry-Kravis), Rush Presbyterian-St. Luke’s Medical Center, Chicago, IL; and the Center for Neurobiology and Behavior (Dr. Arnold), University of Pennsylvania, Philadelphia.
Address correspondence and reprint requests to Dr. David A. Bennett, Rush Alzheimer’s Disease Center, 1645 W. Jackson, Suite 675, Chicago, IL 60612; e-mail: dbennett{at}rush.edu
Objective: To test the hypothesis that the APOE 
4 allele is associated with the clinical manifestations of AD through an association with the pathologic hallmarks of disease.
Methods: Participants were older Catholic nuns, priests, and brothers who agreed to annual neurologic and neuropsychological evaluation for AD and other common neurologic conditions and brain autopsy at the time of death. There were 77 persons without dementia and 51 with probable AD; 38 participants had one or more 4 alleles.
Results: In logistic regression analyses, controlling for age, sex, and education, the 4 allele was strongly associated with the likelihood of clinical AD (odds = 3.46, 95% CI = 1.44 to 8.33). However, controlling for the effect of AD pathology, the association of the allele with clinical AD was reduced by >50% and was no longer significant (odds = 1.58, 95% CI = 0.56 to 4.43). Similarly, in linear regression analyses, controlling for age, sex, and education, the 4 allele was strongly associated with level of cognitive function proximate to death (regression coefficient = -0.477, p = 0.005). However, after controlling for the effect of AD pathology, the association of the 4 allele with level of cognition was reduced by >80% and was no longer significant (regression coefficient = -0.093). Similar results were found in analyses using separate measures of neuritic plaques, diffuse plaques, and neurofibrillary tangles, and in analyses of five different cognitive systems (episodic memory, semantic memory, working memory, perceptual speed, and visuospatial ability).
Conclusions: The APOE 4 allele appears to be associated with the clinical manifestations of AD through an association with the pathologic hallmarks of AD rather than another mechanism.
This article has been cited by other articles:
|
|
 |
|
  Z. Arvanitakis, F. Grodstein, J. L. Bienias, J. A. Schneider, R. S. Wilson, J. F. Kelly, D. A. Evans, and D. A. Bennett Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology Neurology, June 3, 2008; 70(23): 2219 - 2225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Arvanitakis, J. A. Schneider, R. S. Wilson, J. L. Bienias, J. F. Kelly, D. A. Evans, and D. A. Bennett Statins, incident Alzheimer disease, change in cognitive function, and neuropathology Neurology, May 6, 2008; 70(19_Part_2): 1795 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. S. Bell, D. A. Bennett, and A. C. Cuello Paradoxical Upregulation of Glutamatergic Presynaptic Boutons during Mild Cognitive Impairment J. Neurosci., October 3, 2007; 27(40): 10810 - 10817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. A. Mondadori, D. J. -F. de Quervain, A. Buchmann, H. Mustovic, M. A. Wollmer, C. F. Schmidt, P. Boesiger, C. Hock, R. M. Nitsch, A. Papassotiropoulos, et al. Better Memory and Neural Efficiency in Young Apolipoprotein E {varepsilon}4 Carriers Cereb Cortex, August 1, 2007; 17(8): 1934 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Fleisher, B. B. Sowell, C. Taylor, A. C. Gamst, R. C. Petersen, L. J. Thal, and for the Alzheimer's Disease Cooperative Study Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment Neurology, May 8, 2007; 68(19): 1588 - 1595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Wilson, T. L. Beck, J. L. Bienias, and D. A. Bennett Terminal Cognitive Decline: Accelerated Loss of Cognition in the Last Years of Life Psychosom Med, February 1, 2007; 69(2): 131 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Arvanitakis, J. A. Schneider, R. S. Wilson, Y. Li, S. E. Arnold, Z. Wang, and D. A. Bennett Diabetes is related to cerebral infarction but not to AD pathology in older persons Neurology, December 12, 2006; 67(11): 1960 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Lam, N. L. Tang, S. Ma, V. W. Lui, A. S. Chan, P Y Leung, and H. F. Chiu Apolipoprotein epsilon-4 allele and the two-year progression of cognitive function in Chinese subjects with late-onset Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias, March 1, 2006; 21(2): 92 - 99. [Abstract] [PDF]
|
|
|
|
|
|
C.A.R. Martins, A. Oulhaj, C. A. de Jager, and J. H. Williams APOE alleles predict the rate of cognitive decline in Alzheimer disease: A nonlinear model Neurology, December 27, 2005; 65(12): 1888 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D A Bennett, J A Schneider, R S Wilson, J L Bienias, E Berry-Kravis, and S E Arnold Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1194 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Fleischman, R. S. Wilson, J. D. E. Gabrieli, J. A. Schneider, J. L. Bienias, and D. A. Bennett Implicit memory and Alzheimer's disease neuropathology Brain, September 1, 2005; 128(9): 2006 - 2015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Dickerson, D. H. Salat, D. N. Greve, E. F. Chua, E. Rand-Giovannetti, D. M. Rentz, L. Bertram, K. Mullin, R. E. Tanzi, D. Blacker, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD Neurology, August 9, 2005; 65(3): 404 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Barnes, R. S. Wilson, J. L. Bienias, J. A. Schneider, D. A. Evans, and D. A. Bennett Sex Differences in the Clinical Manifestations of Alzheimer Disease Pathology Arch Gen Psychiatry, June 1, 2005; 62(6): 685 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Stoub, M. Bulgakova, S. Leurgans, D. A. Bennett, D. Fleischman, D. A. Turner, and L. deToledo-Morrell MRI predictors of risk of incident Alzheimer disease: A longitudinal study Neurology, May 10, 2005; 64(9): 1520 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Lane and M. R. Farlow Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease J. Lipid Res., May 1, 2005; 46(5): 949 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.A. Schneider, J.L. Bienias, R.S. Wilson, E. Berry-Kravis, D.A. Evans, and D.A. Bennett The Apolipoprotein E {epsilon}4 Allele Increases the Odds of Chronic Cerebral Infarction Detected at Autopsy in Older Persons Stroke, May 1, 2005; 36(5): 954 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Bennett, J. A. Schneider, J. L. Bienias, D. A. Evans, and R. S. Wilson Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions Neurology, March 8, 2005; 64(5): 834 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Bennett and D. M. Holtzman Immunization therapy for Alzheimer disease? Neurology, January 11, 2005; 64(1): 10 - 12. [Full Text] [PDF]
|
|
|
|
|
|
A. Drzezga, M. Riemenschneider, B. Strassner, T. Grimmer, M. Peller, A. Knoll, S. Wagenpfeil, S. Minoshima, M. Schwaiger, and A. Kurz Cerebral glucose metabolism in patients with AD and different APOE genotypes Neurology, January 11, 2005; 64(1): 102 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Farlow, Y. He, S. Tekin, J. Xu, R. Lane, and H. C. Charles Impact of APOE in mild cognitive impairment Neurology, November 23, 2004; 63(10): 1898 - 1901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. den Heijer, S. E Vermeer, E. J van Dijk, N. D Prins, P. J Koudstaal, C. M van Duijn, A. Hofman, and M. M. Breteler Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia Am. J. Clinical Nutrition, October 1, 2004; 80(4): 992 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tiraboschi, L. A. Hansen, E. Masliah, M. Alford, L. J. Thal, and J. Corey-Bloom Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease Neurology, June 8, 2004; 62(11): 1977 - 1983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. F. Tannock, T. A. Ahles, P. A. Ganz, and F. S. van Dam Cognitive Impairment Associated With Chemotherapy for Cancer: Report of a Workshop J. Clin. Oncol., June 1, 2004; 22(11): 2233 - 2239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Arvanitakis, R. S. Wilson, J. L. Bienias, D. A. Evans, and D. A. Bennett Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function Arch Neurol, May 1, 2004; 61(5): 661 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Schneider, R. S. Wilson, J. L. Bienias, D. A. Evans, and D. A. Bennett Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology Neurology, April 13, 2004; 62(7): 1148 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Bennett, R. S. Wilson, J. A. Schneider, J. L. Bienias, and S. E. Arnold Cerebral Infarctions and the Relationship of Depression Symptoms to Level of Cognitive Functioning in Older Persons Am J Geriatr Psychiatry, April 1, 2004; 12(2): 211 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Bennett, J. A. Schneider, R. S. Wilson, J. L. Bienias, and S. E. Arnold Neurofibrillary Tangles Mediate the Association of Amyloid Load With Clinical Alzheimer Disease and Level of Cognitive Function Arch Neurol, March 1, 2004; 61(3): 378 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Wilson, D. A. Evans, J. L. Bienias, C. F. Mendes de Leon, J. A. Schneider, and D. A. Bennett Proneness to psychological distress is associated with risk of Alzheimer's disease Neurology, December 9, 2003; 61(11): 1479 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.S. Wilson, J.A. Schneider, J.L. Bienias, S.E. Arnold, D.A. Evans, and D.A. Bennett Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons Neurology, October 28, 2003; 61(8): 1102 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Bennett, R. S. Wilson, J. A. Schneider, D. A. Evans, C. F. Mendes de Leon, S. E. Arnold, L. L. Barnes, and J. L. Bienias Education modifies the relation of AD pathology to level of cognitive function in older persons Neurology, June 24, 2003; 60(12): 1909 - 1915. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
